Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates

Precision BioSciences (DTIL) came out with a quarterly loss of $2.13 per share versus the Zacks Consensus Estimate of a loss of$ 0.09. This compares to earnings of $3.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -2,266.67%. A quarter ago, it was expected that this genome editing company would post a loss of$ 0.43 per share when it actually produced a loss of $2.21, delivering a surprise of -413.95%. Over the last four q ...